Snowdon Pharmaceuticals

Snowdon Pharmaceuticals was a discovery-stage biotechnology company focused on the development of small molecule therapeutics using a proprietary structure-based drug design platform. The company is most notable for its foundational research into Selective Androgen Receptor Modulators (SARMs), which were designed to treat conditions such as muscle wasting and osteoporosis. This intellectual property was subsequently licensed to GTx, Inc., which advanced the programs into clinical development. Snowdon also maintained research programs in infectious diseases, specifically targeting the Hepatitis C virus (HCV) protease, and established collaborations with major pharmaceutical firms like Wyeth. Although the company is no longer active, its early work in nuclear receptor modulation significantly influenced the development of the SARM therapeutic class.